SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells

Cancer Research

Volumn 63, Issue 5, 2003, Pages 1054-1058

  Dallol, Ashraf ^a   Morton, Dion ^a   Maher, Eamonn R ^a   Latif, Farida ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; GENE SILENCING; GENE SLIT2; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MARKER GENE; METHYLATION; ONCOGENE K RAS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BASE SEQUENCE; CELL DIVISION; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, P16; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0037374598     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jubb, A. M., Bell, S. M., and Quirke, P. Methylation and colorectal cancer. J. Pathol., 195: 111-134, 2001.
2. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
3. Toyota, M., Ohe-Toyota, M., Ahuja, N., and Issa, J. P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA, 97: 710-715, 2000.
4. Dallol, A., Da Silva, N. F., Viacava, P., Minna, J. D., Bieche, I., Maher, E. R., and Latif, F. SLIT2, a human homologue of the Drosophila Slit2 gene has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res. 62: 5874-5880, 2002.
5. Wu, J. Y., Feng, L., Park, H. T., Havlioglu, N., Wen, L., Tang, H., Bacon. K. B., Jiang, Z., Zhang, X., and Rao, Y. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature (Lond.), 410: 948-952, 2001.
6. Wong, K., Ren, X. R., Huang. Y. Z., Xie, Y., Liu, G., Saito, H., Tang, H., Wen, L., Brady-Kalnay, S. M., Mei, L., Wu, J. Y., Xiong, W. C., and Rao, Y. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell, 107: 209-221, 2001.
7. Stein, E., and Tessier-Lavigne, M. Hierarchical organiz ation of guidance receptors: silencing of netrin attraction by slit through a Robo/DCC receptor complex. Science (Wash. DC), 291: 1928-1938, 2001.
8. Forcet, C., Ye, X., Granger, L., Corset, V., Shin, H., Bredesen, D. E., and Mehlen, P. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc. Natl. Acad. Sci. USA, 98: 3416-3421, 2001.
9. Georgas, K., Burridge, L., Smith, K., Holmes, G. P., Chenevix-Trench, G., Ioannou, P. A., and Little, M. H. Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2. Cytogenet. Cell Genet., 86: 246-247, 1999.
10. Shivapurkar, N., Maitra, A., Milchgrub, S., and Gazdar, A. F. Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum. Pathol., 32: 169-177, 2001.
11. Shivapurkar, N., Virmani, A. K., Wistuba, I. I., Mitchgrub, S., Mackay, B., Minna, J. D., and Gazdar, A. F. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin. Cancer Res., 5: 17-23, 1999.
12. Shivapurkar, N., Sood, S., Wistuba, I. I., Virmani, A. K., Maitra, A., Milchgrub, S., Minna, J. D., and Gazdar, A. F. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res., 59: 3576-3580, 1999.
13. Wagner, K. J., Cooper, W. N., Grundy, R. G., Caldwell, G., Jones, C., Wadey, R. B., Morton, D., Reik, W., Latif, F., and Maher, E. R. Frequent RASSFIA tumour suppressor gene promoter methylation in Wilm's tumour and colorectal cancer. Oncogene, 21: 7277-7282, 2002.
14. Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., Hosoe, S., Lerman, M. I., Minna, J. D., Maher, E. R., and Latif, F. Methylation associated inactivation of RASSFIA from region 3p21.3 in lung, breast and ovarian tumours. Oncogene, 20: 1509-1518, 2001.
15. Dallol, A., Forgacs, E., Martinez, A., Sekido, Y., Walker, R., Kishida, T., Rabbitts, P., Maher, E. R., and Latif, F. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTTI (ROBOI) in human cancers. Oncogene, 21: 3020-3028, 2002.
16. Nguyen Ba-Charvet, K. T., Brose, K., Ma, L., Wang, K. H., Marillat, V., Sotelo, C., Tessier-Lavigne, M., and Chedotal, A. Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance. J. Neurosci., 21: 4281-4289, 2001.
17. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
18. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
19. Yu, T. W., and Bargmann, C. I. Dynamic regulation of axon guidance. Nat. Neurosci., 4 (Suppl.): 1169-1176, 2001.
20. Tse, C., Xiang, R. H., Bracht, T., and Naylor, S. L. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res., 62: 542-546, 2002.
21. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M. I., Gazdar, A. F., and Minna, J. D. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl. Acad. Sci. USA. 98: 13954-13959, 2001.
22. Ochi, K., Mori, T., Toyama, Y., Nakamura, Y., and Arakawa, H. Identification of semaphorin3B as a direct target of p53. Neoplasia, 4: 82-87, 2002.
23. Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jr., Jessup, J. M., Loda, M., and Summerhayes, I. C. The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med., 335: 1727-1732, 1996.
24. Sato, K., Tamura, G., Tsuchiya, T., Endoh, Y., Usuba, O., Kimura, W., and Motoyama, T. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br. J. Cancer, 85: 199-203, 2001.
25. Dammann, R., Yang, G., and Pfeifer, G. P. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res., 61: 3105-3109, 2001.